PSME3 and gastric cancer: Nevertheless, the upregulation of PSME3 was negatively correlated with better OS in male and female GC patients, both HER2-positive and HER2-negative, intestinal and mixed classification, poor and well differentiation, and 5-FU-based adjuvant treatment.